Patients with high expressions of FMR1, LRPPRC, METTL14, RBMX, YTHDC2, YTHDF2, YTHDF3 and low expression of IGF2BP1 possess poor prognosis in CRC. The gene discussed is METTL14; the disease is colorectal carcinoma.